Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Controlled trials in epilepsy: a review.

L Gram, K D Bentsen, J Parnas

    Epilepsia
    |October 1, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The neurophenomenology of early psychosis: An integrative empirical study.

    Consciousness and cognition·2019
    Same author

    L'Encephale·2019
    Same author

    Exploring social cognition in schizophrenia.

    European archives of psychiatry and clinical neuroscience·2016
    Same author

    Temporal persistence of anomalous self-experience: A 5years follow-up.

    Schizophrenia research·2016
    Same author

    Pathologies of imagination in schizophrenia spectrum disorders.

    Acta psychiatrica Scandinavica·2014
    Same author

    [Epizootic diseases in Poland with special reference to zoonosis].

    Postepy higieny i medycyny doswiadczalnej·2014
    Same journal

    Responsible use of artificial intelligence in peer-reviewed publications in epilepsy.

    Epilepsia·2026
    Same journal

    Altered autonomic balance drives the increase in cardiac output and arterial pressure during convulsive seizures in nonanesthetized sheep.

    Epilepsia·2026
    Same journal

    Diagnostic yield and copy number variants findings in 219 adult patients with developmental and epileptic encephalopathy.

    Epilepsia·2026
    Same journal

    Prolonged fenfluramine use in open-label studies of Dravet or Lennox-Gastaut syndromes: Long-term safety, tolerability, patient global functioning, and considerations for interpreting effectiveness.

    Epilepsia·2026
    Same journal

    Electrocardiography characteristics and long-term mortality in people with epilepsy from a resource-poor community.

    Epilepsia·2026
    Same journal

    Factors associated with rapid pediatric acute seizure emergency treatment: Quality Improvement in Time to Treat Status Epilepticus baseline cohort.

    Epilepsia·2026
    See all related articles

    This review of 51 epilepsy studies found common trial designs had limitations. Results indicate current research offers no clear guidance on the best antiepileptic drug for specific seizure types.

    Area of Science:

    • Neurology
    • Clinical Trials
    • Epilepsy Research

    Background:

    • Epileptology research relies heavily on randomized controlled trials.
    • Understanding the efficacy and safety of antiepileptic drugs (AEDs) is crucial for patient care.
    • Previous reviews have not synthesized findings across diverse epilepsy trial methodologies.

    Purpose of the Study:

    • To comprehensively review 51 randomized double-blind controlled studies in epileptology.
    • To analyze trial designs, patient selection, outcome measures, and statistical methods.
    • To identify limitations and derive overall conclusions where possible.

    Main Methods:

    • Systematic review and cross-sectional analysis of 51 randomized double-blind controlled trials.
    • Grouping studies by topic: antiepileptic drug treatments, psychotropic effects, nutritional supplements, and EEG.

    Related Experiment Videos

  • Evaluating study design elements including crossover designs, washout periods, patient heterogeneity, and data collection.

    • Main Results:

    • The majority of studies focused on antiepileptic drug treatments, often using crossover designs without adequate washout periods.
    • Significant heterogeneity in patient selection (age, seizure type, epilepsy severity) complicated analyses.
    • Trial durations were short (mean 6 months), precluding chronic toxicity assessment, and side effect data collection was often unsystematic.
    • Concomitant medication changes hindered evaluation of drug effects.
    • No evidence supported the assumption that short trials yield overly optimistic results.
    • The review could not determine which antiepileptic drug is most suitable for specific seizure types.

    Conclusions:

    • Current randomized controlled trials in epileptology exhibit methodological limitations, including patient heterogeneity and inadequate washout periods.
    • The reviewed studies provide insufficient evidence to guide the selection of specific antiepileptic drugs for different seizure types.
    • Further research with standardized methodologies and patient stratification is needed to optimize epilepsy treatment.